Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by 90guppyon Jul 31, 2020 7:22pm
76 Views
Post# 31352552

RE:RE:RE:Bliglicka you called it bang on

RE:RE:RE:Bliglicka you called it bang onThat's right, it was a good decision by management to cancel. Never too late to walk away and be associated with a broker twice penalized IIROC for the last five years. 
https://www.investmentexecutive.com/news/from-the-regulators/iiroc-fines-dealer-for-failure-to-comply-with-trading-supervision-obligations/




kevlin139 wrote:

lets hope he cancelled it because the company has the goods and raising money at this valuation and manipulation is terrible.... lets face it theres no way they couldnt raise money for a vaccine in this pandemic no matter what!

 

bligicka wrote: The pp was super sketchy l wonder if Dave canceled it after realizing the potential liabilities involved with the circumstances ....ie lawsuits or securities laws

 

kevlin139 wrote: You were correct all along!

 




<< Previous
Bullboard Posts
Next >>